Iron and genome stability: An update

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 733, Issue 1-2, 2012, Pages 92-99

  Prá, Daniel ^a,b   Franke, Silvia Isabel Rech ^a   Henriques, João Antonio Pêgas ^c   Fenech, Michael ^d  

^a UNIVERSITY OF SANTA CRUZ DO SUL   (Brazil)

^b CATHOLIC UNIVERSITY OF PELOTAS   (Brazil)

^c UNIVERSITY OF CAXIAS DO SUL   (Brazil)

^d CSIRO   (Australia)

Author keywords

Anemia; Cancer; Genome stability; Hemochromatosis; Iron deficiency; Iron overload; Oxidative stress

Indexed keywords

IRON;

ANEMIA; CANCER RISK; CELL DEATH; DIETARY REFERENCE INTAKE; DNA DAMAGE; GASTROINTESTINAL SYMPTOM; GENE MUTATION; GENOMIC INSTABILITY; HEMOCHROMATOSIS; HUMAN; IRON DEFICIENCY; IRON INTAKE; IRON OVERLOAD; IRON THERAPY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; RISK REDUCTION;

DNA DAMAGE; GENOMIC INSTABILITY; HUMANS; IRON; IRON OVERLOAD; NUTRITIONAL REQUIREMENTS; OXIDATIVE STRESS; TRACE ELEMENTS;

EID: 84860578242     PISSN: 00275107     EISSN: 09218262     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2012.02.001     Document Type: Review

References (124)

1. Lopez M.A., Martos F.C. Iron availability: an updated review. Int. J. Food Sci. Nutr. 2004, 55:597-606.
2. Shakoury-Elizeh M., Protchenko O., Berger A., Cox J., Gable K., Dunn T.M., Prinz W.A., Bard M., Philpott C.C. Metabolic response to iron deficiency in Saccharomyces cerevisiae. J. Biol. Chem. 2010, 285:14823-14833.
3. Anderson G.J., Frazer D.M. Hepatic iron metabolism. Semin. Liver Dis. 2005, 25:420-432.
4. Prá D., Franke S.I.R., Henriques J.A.P., Fenech M. A possible link between iron deficiency and gastrointestinal carcinogenesis. Nutr. Cancer 2009, 61:415-426.
5. Anderson G.J., Frazer D.M., McKie A.T., Vulpe C.D., Smith A. Mechanisms of Haem and Non-Haem iron absorption: lessons from inherited disorders of iron metabolism. BioMetals 2005, 18:339-348.
6. Arredondo M., Nunez M.T. Iron and copper metabolism. Mol. Aspects Med. 2005, 26:313-327.
7. Oliveira M.A.A., Osório M.M. Cow's milk consumption and iron deficiency anemia in children. J. Pediatr. (Rio J.) 2005, 81:361-367.
8. Umbreit J. Iron deficiency: a concise review. Am. J. Hematol. 2005, 78:225-231.
9. Cook J.D., Lynch S.R. The liabilities of iron deficiency. Blood 1986, 68:803-809.
10. Templeton D.M., Liu Y. Genetic regulation of cell function in response to iron overload or chelation. BBA Gen. Subjects 2003, 1619:113-124.
11. Papanikolaou G., Pantopoulos K. Iron metabolism and toxicity. Toxicol. Appl. Pharmacol. 2005, 202:199-211.
12. Trost L.B., Bergfeld W.F., Calogeras E. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. J. Am. Acad. Dermatol. 2006, 54:824-844.
13. Ozcay F., Derbent M., Aldemir D., Turkoglu S., Baskin E., Ozbek N., Saatci U. Effect of iron deficiency anemia on renal tubular function in childhood. Pediatr. Nephrol. 2003, 18:254-256.
14. Beard J.L. Iron biology in immune function, muscle metabolism and neuronal functioning. J Nutr. 2001, 131:568S-579S. (discussion 580S).
15. Zimmermann M.B., Hurrell R.F. Nutritional iron deficiency. Lancet 2007, 370:511-520.
16. Ortiz E., Pasquini J.M., Thompson K., Felt B., Butkus G., Beard J., Connor J.R. Effect of manipulation of iron storage, transport, or availability on myelin composition and brain iron content in three different animal models. J. Neurosci. Res. 2004, 77:681-689.
17. Lee H.S., Kim M.S., Kim M.H., Kim Y.J., Kim W.Y. Iron status and its association with pregnancy outcome in Korean pregnant women. Eur. J. Clin. Nutr. 2006, 60:1130-1135.
18. Hernandez-Martinez C., Canals J., Aranda N., Ribot B., Escribano J., Arija V. Effects of iron deficiency on neonatal behavior at different stages of pregnancy. Early Hum. Dev. 2011, 87:165-169.
19. Milman N. Iron and pregnancy - a delicate balance. Ann. Hematol. 2006, 85:559-565.
20. Jones P. Catalytic mechanisms and reactivity of peroxidases, catalases and iron-porphyrin model systems. Inorg. Chim. Acta 1983, 79:177-178.
21. Mishina Y., He C. Oxidative dealkylation DNA repair mediated by the mononuclear non-heme iron AlkB proteins. J. Inorg. Biochem. 2006, 100:670-678.
22. Klinge S., Hirst J., Maman J.D., Krude T., Pellegrini L. An iron-sulfur domain of the eukaryotic primase is essential for RNA primer synthesis. Nat. Struct. Mol. Biol. 2007, 14:875-877.
23. Mishina Y., Duguid E.M., He C. Direct reversal of DNA alkylation damage. Chem. Rev. 2006, 106:215-232.
24. White M.F. Structure, function and evolution of the XPD family of iron-sulfur-containing 5'→3' DNA helicases. Biochem. Soc. Trans. 2009, 37:547-551.
25. Hiom K. FANCJ: solving problems in DNA replication. DNA Repair 2010, 9:250-256.
26. Brzoska K., Meczynska S., Kruszewski M. Iron-sulfur cluster proteins: electron transfer and beyond. Acta Biochim. Pol. 2006, 53:685-691.
27. Macdougall L.G. Red cell metabolism in iron deficiency anemia: III. The relationship between glutathione peroxidase, catalase, serum vitamin E, and susceptibility of iron-deficient red cells to oxidative hemolysis. J. Pediatr. 1972, 80:775-782.
28. Acharya J., Punchard N.A., Taylor J.A., Thompson R.P.H., Pearson T.C. Red-cell lipid-peroxidation and antioxidant enzymes in iron-deficiency. Eur. J. Hematol. 1991, 47:287-291.
29. Knutson M.D., Walter P.B., Ames B.N., Viteri F.E. Both iron deficiency and daily iron supplements increase lipid peroxidation in rats. J. Nutr. 2000, 130:621-628.
30. Kurtoglu E., Ugur A., Baltaci A.K., Undar L. Effect of iron supplementation on oxidative stress and antioxidant status in iron-deficiency anemia. Biol. Trace Elem. Res. 2003, 96:117-123.
31. Furukawa T., Naitoh Y., Kohno H., Tokunaga R., Taketani S. Iron deprivation decreases ribonucleotide reductase activity and DNA synthesis. Life Sci. 1992, 50:2059-2065.
32. Weiner B.E., Huang H., Dattilo B.M., Nilges M.J., Fanning E., Chazin W.J. An iron-sulfur cluster in the C-terminal domain of the p58 subunit of human DNA primase. J. Biol. Chem. 2007, 282:33444-33451.
33. Wen W.Q., Shu X.O., Potter J.D., Severson R.K., Buckley J.D., Reaman G.H., Robison L.L. Parental medication use and risk of childhood acute lymphoblastic leukemia. Cancer 2002, 95:1786-1794.
34. Schuz J., Weihkopf T., Kaatsch P. Medication use during pregnancy and the risk of childhood cancer in the offspring. Eur. J. Pediatr. 2007, 166:433-441.
35. Berrak S.G., Angaji M., Turkkan E., Canpolat C., Timur C., Eksioglu-Demiralp E. The effects of iron deficiency on neutrophil/monocyte apoptosis in children. Cell Proliferat. 2007, 40:741-754.
36. Atamna H., Liu J., Ames B.N. Heme deficiency selectively interrupts assembly of mitochondrial complex IV in human fibroblasts: revelance to aging. J. Biol. Chem. 2001, 276:48410-48416.
37. Walter P.B., Knutson M.D., Paler-Martinez A., Lee S., Xu Y., Viteri F.E., Ames B.N. Iron deficiency and iron excess damage mitochondria and mitochondrial DNA in rats. PNAS 2002, 99:2264-2269.
38. Atamna H., Killilea D.W., Killilea A.N., Ames B.N. Heme deficiency may be a factor in the mitochondrial and neuronal decay of aging. PNAS 2002, 99:14807-14812.
39. Kempe D.S., Lang P.A., Duranton C., Akel A., Lang K.S., Huber S.M., Wieder T., Lang F. Enhanced programmed cell death of iron-deficient erythrocytes. FASEB J. 2005, 05-4872fje.
40. Aslan M., Horoz M., Kocyigit A., Ozgonul S., Celik H., Celik M., Erel O. Lymphocyte DNA damage and oxidative stress in patients with iron deficiency anemia. Mutat. Res. 2006, 601:144-149.
41. Diaz-Castro J., Alferez M.J., Lopez-Aliaga I., Nestares T., Granados S., Barrionuevo M., Campos M.S. Influence of nutritional iron deficiency anemia on DNA stability and lipid peroxidation in rats. Nutrition 2008, 24:1167-1173.
42. Aksu B.Y., Hasbal C., Himmetoglu S., Dincer Y., Koc E.E., Hatipoglu S., Akcay T. Leukocyte DNA damage in children with iron deficiency anemia: effect of iron supplementation. Eur. J. Pediatr. 2010, 169:951-956.
43. Prá D., Bortoluzzi A., Müller L.L., Hermes L., Horta J.A., Malul S.W., Henriques J.A.P., Fenech M., Franke S.I.R. Iron intake, red cell indicators of iron status and DNA damage in young subjects. Nutrition 2011, 27:293-297.
44. Kovacevic Z., Richardson D.R. Tuning cell cycle regulation with an iron key. Cell Cycle 2007, 6:1982-1994.
45. Kulp K.S., Green S.L., Vulliet P.R. Iron deprivation inhibits cyclin-dependent kinase activity and decreases cyclin D CDK4 protein levels in asynchronous MDA-MB-453 human breast cancer cells. Exp. Cell Res. 1996, 229:60-68.
46. Bai J., Cederbaum A.I. Overexpression of catalase in the mitochondrial or cytosolic compartment increases sensitivity of HepG2 cells to tumor necrosis factor-alpha-induced apoptosis. J. Biol. Chem. 2000, 275:19241-19249.
47. Payne C.M., Holubec H., Bernstein C., Bernstein H., Dvorak K., Green S.B., Wilson M., Dall'Agnol M., Dvorakova B., Warneke J., Garewal H. Crypt-restricted loss and decreased protein expression of cytochrome c oxidase subunit I as potential hypothesis-driven biomarkers of colon cancer risk. Cancer Epidemiol. Biomarkers Prev. 2005, 14:2066-2075.
48. Atamna H. Heme, iron, and the mitochondrial decay of ageing. Ageing Res. Rev. 2004, 3:303-318.
49. Dhur A., Galan P., Hercberg S. Effects of different degrees of iron deficiency on cytochrome P450 complex and pentose phosphate pathway dehydrogenases in the rat. J. Nutr. 1989, 119:40-47.
50. Aslan M., Kosecik M., Horoz M., Selek S., Celik H., Erel O. Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia. Atherosclerosis 2007, 191:397-402.
51. Arioz D.T., Camuzcuoglu H., Toy H., Kurt S., Celik H., Erel O. Assessment of serum paraoxonase and arylesterase activity in patients with endometrial cancer. Eur. J. Gynaecol. Oncol. 2009, 30:679-682.
52. Camuzcuoglu H., Arioz D.T., Toy H., Kurt S., Celik H., Erel O. Serum paraoxonase and arylesterase activities in patients with epithelial ovarian cancer. Gynecol. Oncol. 2009, 112:481-485.
53. Murakawa H., Bland C.E., Willis W.T., Dallman P.R. Iron deficiency and neutrophil function: different rates of correction of the depressions in oxidative burst and myeloperoxidase activity after iron treatment. Blood 1987, 69:1464-1468.
54. Harhaji L., Vuckovic O., Miljkovic D., Stosic-Grujicic S., Trajkovic V. Iron down-regulates macrophage anti-tumour activity by blocking nitric oxide production. Clin. Exp. Imunol. 2004, 137:109-116.
55. Goldblatt M.I., Choi S.-H., Swartz-Basile D.A., Nakeeb A., Sarna S.K., Pitt H.A. Iron deficiency suppresses ileal nitric oxide synthase activity. J. Gastrointest. Surg. 2001, 5:393-400.
56. Ohshima H., Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat. Res. 1994, 305:253-264.
57. Anderson A.C. Iron poisoning in children. Curr. Opin. Pediatr. 1994, 6:289-294.
58. Tenenbein M. Unit-dose packaging of iron supplements and reduction of iron poisoning in young children. Arch. Pediatr. Adolesc. Med. 2005, 159:557-560.
59. IOM Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Molybdenum, Nickel, Sillicon, Vanadium and Zinc. Food and Nutrition Board 2001, National Academy Press, Washington, DC.
60. Schümann K. Safety aspects of iron in food. Ann. Nutr. Metab. 2001, 45:91-101.
61. Ahmed F.E. Effect of diet, life style, and other environmental/chemopreventive factors on colorectal cancer development, and assessment of the risks. J. Environ. Sci. Health C Environ. Carcinogen. Ecotoxicol. Rev. 2004, 22:91-147.
62. Cabantchik Z.I., Breuer W., Zanninelli G., Cianciulli P. LPI-labile plasma iron in iron overload. Best Pract. Res. Clin. Haematol. 2005, 18:277-287.
63. Fredriksson A., Schroder N., Eriksson P., Izquierdo I., Archer T. Neonatal iron exposure induces neurobehavioural dysfunctions in adult mice. Toxicol. Appl. Pharmacol. 1999, 159:25-30.
64. Oppenheimer S.J. Iron and its relation to immunity and infectious disease. J. Nutr. 2001, 131:616S-635S.
65. Vyoral D., Petrak J. Hepcidin: a direct link between iron metabolism and immunity. Int. J. Biochem. Cell Biol. 2005, 37:1673-1768.
66. Gattermann N. The treatment of secondary hemochromatosis. Dtsch. Arztebl. Int. 2009, 106:499-504.
67. Scheinberg I.H. The genetics of hemochromatosis. Arch. Intern. Med. 1973, 132:126-128.
68. Huang X. Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal. Mutat. Res. 2003, 533:153-171.
69. Huang X. Iron overload as a risk factor and molecular mechanism of carcinogenesis. Environ. Mol. Mutagen 2004, 44. 206-206.
70. Bhasin G., Kauser H., Athar M. Iron augments stage-I and stage-II tumor promotion in murine skin. Cancer Lett. 2002, 183:113-122.
71. Messner D.J., Kowdley K.V. Neoplastic transformation of rat liver epithelial cells is enhanced by non-transferrin-bound iron. BMC Gastroenterol. 2008, 8:2.
72. Kucharzewski M., Braziewicz J., Majewska U., Gozdz S. Iron concentrations in intestinal cancer tissue and in colon and rectum polyps. Biol. Trace Elem. Res. 2003, 95:19-28.
73. Jakszyn P., Agudo A., Lujan-Barroso L., Bueno-de-Mesquita H.B., Jenab M., Navarro C., Palli D., Boeing H., Manjer J., Numans M.E., Igali L., Boutron-Ruault M.C., Clavel-Chapelon F., Morois S., Grioni S., Panico S., Tumino R., Sacerdote C., Quiros J.R., Molina-Montes E., Castano J.M., Barricarte A., Amiano P., Khaw K.T., Wareham N., Allen N.E., Key T.J., Jeurnink S.M., Peeters P.H., Bamia C., Valanou E., Trichopoulou A., Kaaks R., Lukanova A., Bergmann M.M., Lindkvist B., Stenling R., Johansson I., Dahm C.C., Overvad K., Olsen A., Tjonneland A., Skeie G., Broderstad A.R., Lund E., Michaud D.S., Mouw T., Riboli E., Gonzalez C.A. Dietary intake of heme iron and risk of gastric cancer in the European prospective investigation into cancer and nutrition (EURGAST-EPIC) study. Int. J. Cancer 2012, 130(11):2654-2663.
74. Crawford R.D. The case for iron repletion as a promoter in testicular cancer. Med. Hypotheses 1998, 51:129-132.
75. Kabat G.C., Rohan T.E. Does excess iron play a role in breast carcinogenesis? An unresolved hypothesis. Cancer Causes Control 2007, 18:1047-1053.
76. Chen J., Chloupkova M. Abnormal iron uptake and liver cancer. Cancer Biol. Ther. 2009, 8:1699-1708.
77. Deugnier Y. Iron and liver cancer. Alcohol 2003, 30:145-150.
78. Liehr J.G., Jones J.S. Role of iron in estrogen-induced cancer. Curr. Med. Chem. 2001, 8:839-849.
79. Pellis L., Dommels Y., Venema D., Polanen A., Lips E., Baykus H., Kok F., Kampman E., Keijer J. High folic acid increases cell turnover and lowers differentiation and iron content in human HT29 colon cancer cells. Br. J. Nutr. 2008, 99:703-708.
80. Cragg L., Hebbel R.P., Miller W., Solovey A., Selby S., Enright H. The iron chelator L1 potentiates oxidative DNA damage in iron-loaded liver cells. Blood 1998, 92:632-638.
81. Zacharski L.R., Chow B.K., Howes P.S., Shamayeva G., Baron J.A., Dalman R.L., Malenka D.J., Ozaki C.K., Lavori P.W. Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial. J. Natl. Cancer Inst. 2008, 100:996-1002.
82. Toyokuni S. Iron as a target of chemoprevention for longevity in humans. Free Radic. Res. 2011, 45:906-917.
83. Reveiz L., Gyte G.M.L., Cuervo L.G. Treatments for iron-deficiency anaemia in pregnancy. Cochrane Database Syst. Rev. 2007, 2. CD003094.
84. Reveiz L., Gyte G.M.L., Cuervo L.G., Casasbuenas A. Treatments for iron-deficiency anaemia in pregnancy. Cochrane Database Syst. Rev. 2011, 10. CD003094.
85. Banhidy F., Acs N., Puho E.H., Czeizel A.E. Iron deficiency anemia: pregnancy outcomes with or without iron supplementation. Nutrition 2011, 27:65-72.
86. Zhou S.J., Gibson R.A., Crowther C.A., Baghurst P., Makrides M. Effect of iron supplementation during pregnancy on the intelligence quotient and behavior of children at 4 y of age: long-term follow-up of a randomized controlled trial. Am. J. Clin. Nutr. 2006, 83:1112-1117.
87. Parsons A.G., Zhou S.J., Spurrier N.J., Makrides M. Effect of iron supplementation during pregnancy on the behaviour of children at early school age: long-term follow-up of a randomised controlled trial. Brit. J. Nutr. 2008, 99:1133-1139.
88. Ziaei S., Norrozi M., Faghihzadeh S., Jafarbegloo E. A randomized palceebo-controlled trial to determine the effect of iron supplementation on pregnancy outcome in pregnant women with haemoglobin≥13.2g/dl. BJOG 2007, 114:684-688.
89. Ouladsahebmadarek E., Sayyah-Melli M., Taghavi S., Abbasalizadeh S., Seyedhejazie M. The effect of supplemental iron elimination on pregnancy outcome. Pak. J. Med. Sci. 2011, 27:641-645.
90. Devrim E., Tarhan I., Erguder I.B., Durak I. Oxidant/antioxidant status of placenta, blood, and cord blood samples from pregnant women supplemented with iron. J. Soc. Gynecol. Investig. 2006, 13:502-505.
91. Halliwell B., Guterridge J.M.C. Free Radicals in Biology and Medicine 2000, Oxford University Press, New York.
92. Puppo A., Halliwell B. Formation of hydroxyl radicals from hydrogen peroxide in the presence of iron. Is haemoglobin a biological Fenton reagent?. Biochem. J. 1988, 249:185-190.
93. Heidelberger C., Freeman A.E., Pienta R.J., Sivak A., Bertram J.S., Casto B.C., Dunkel V.C., Francis M.W., Kakunaga T., Little J.B., Schechtman L.M. Cell transformation by chemical agents-a review and analysis of the literature. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat. Res. 1983, 114:283-385.
94. Abalea V., Cillard J., Dubos M.P., Sergent O., Cillard P., Morel I. Repair of iron-induced DNA oxidation by the flavonoid myricetin in primary rat hepatocyte cultures. Free Radic. Biol. Med. 1999, 26:1457-1466.
95. Dunkel V.C., San R.H., Seifried H.E., Whittaker P. Genotoxicity of iron compounds in Salmonella typhimurium and L5178Y mouse lymphoma cells. Environ. Mol. Mutagen 1999, 33:28-41.
96. Hussain S.P., Raja K., Amstad P.A., Sawyer M., Trudel L.J., Wogan G.N., Hofseth L.J., Shields P.G., Billiar T.R., Trautwein C., Hohler T., Galle P.R., Phillips D.H., Markin R., Marrogi A.J., Harris C.C. Increased p53 mutation load in nontumorous human liver of Wilson disease and hemochromatosis: oxyradical overload diseases. PNAS 2000, 97:12770-12775.
97. Gushima M., Hirahashi M., Matsumoto T., Fujita K., Fujisawa R., Mizumoto K., Nakabeppu Y., Iida M., Yao T., Tsuneyoshi M. Altered expression of MUTYH and an increase in 8-hydroxydeoxyguanosine are early events in ulcerative colitis-associated carcinogenesis. J. Pathol. 2009, 219:77-86.
98. Nakano M., Kawanishi Y., Kamohara S., Uchida Y., Shiota M., Inatomi Y., Komori T., Miyazawa K., Gondo K., Yamasawa I. Oxidative DNA damage (8-hydroxydeoxyguanosine) and body iron status: a study on 2507 healthy people. Free Radic. Biol. Med. 2003, 35:826-832.
99. Morel I., Hamon-Bouer C., Abalea V., Cillard P., Cillard J. Comparison of oxidative damage of DNA and lipids in normal and tumor rat hepatocyte cultures treated with ferric nitrilotriacetate. Cancer Lett. 1997, 119:31-36.
100. Cao H., Wang Y. Quantification of oxidative single-base and intrastrand cross-link lesions in unmethylated and CpG-methylated DNA induced by Fenton-type reagents. Nucleic Acids Res. 2007, 35:4833-4844.
101. Prá D., Franke S.I., Giulian R., Yoneama M.L., Dias J.F., Erdtmann B., Henriques J.A.P. Genotoxicity and mutagenicity of iron and copper in mice. BioMetals 2008, 21:289-297.
102. Dianov G.L., Timchenko T.V., Sinitsina O.I., Kuzminov A.V., Medvedev O.A., Salganik R.I. Repair of uracil residues closely spaced on the opposite strands of plasmid DNA results in double-strand break and deletion formation. Mol. Gen. Genet. 1991, 225:448-452.
103. Bull C., Fenech M. Genome-health nutrigenomics and nutrigenetics: nutritional requirements or 'nutriomes' for chromosomal stability and telomere maintenance at the individual level. Proc. Nutr. Soc. 2008, 67:146-156.
104. Box H.C., Dawidzik J.B., Budzinski E.E. Free radical-induced double lesions in DNA. Free Radic. Biol. Med. 2001, 31:856-868.
105. Lloyd D.R., Carmichael P.L., Phillips D.H. Comparison of the formation of 8-hydroxy-2'-deoxyguanosine and single- and double-strand breaks in DNA mediated by fenton reactions. Chem. Res. Toxicol. 1998, 11:420-427.
106. Lloyd D.R., Phillips D.H., Carmichael P.L. Generation of putative intrastrand cross-links and strand breaks in DNA by transition metal ion-mediated oxygen radical attack. Chem. Res. Toxicol. 1997, 10:393-400.
107. Lehmann U., Wingen L.U., Brakensiek K., Wedemeyer H., Becker T., Heim A., Metzig K., Hasemeier B., Kreipe H., Flemming P. Epigenetic defects of hepatocellular carcinoma are already found in non-neoplastic liver cells from patients with hereditary haemochromatosis. Hum. Mol. Genet. 2007, 16:1335-1342.
108. Valinluck V., Tsai H.H., Rogstad D.K., Burdzy A., Bird A., Sowers L.C. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res. 2004, 32:4100-4108.
109. Xu Q., Parks C.G., DeRoo L.A., Cawthon R.M., Sandler D.P., Chen H. Multivitamin use and telomere length in women. Am. J. Clin. Nutr. 2009, 89:1857-1863.
110. Liu Q., Wang H., Hu D., Ding C., Xu H., Tao D. Effects of trace elements on the telomere lengths of hepatocytes L-02 and hepatoma cells SMMC-7721. Biol. Trace Elem. Res. 2004, 100:215-227.
111. Brown K.E., Meleah Mathahs M., Broadhurst K.A., Coleman M.C., Ridnour L.A., Schmidt W.N., Spitz D.R. Increased hepatic telomerase activity in a rat model of iron overload: a role for altered thiol redox state?. Free Radic. Biol. Med. 2007, 42:228-235.
112. Gao X., Campian J.L., Qian M., Sun X.F., Eaton J.W. Mitochondrial DNA damage in iron overload. J. Biol. Chem. 2009, 284:4767-4775.
113. Gao X., Qian M., Campian J.L., Marshall J., Zhou Z., Roberts A.M., Kang Y.J., Prabhu S.D., Sun X.F., Eaton J.W. Mitochondrial dysfunction may explain the cardiomyopathy of chronic iron overload. Free Radic. Biol. Med. 2010, 49:401-407.
114. Fenech M. Recommended dietary allowances (RDAs) for genomic stability. Mutat. Res. 2001, 480-481:51-54.
115. Fenech M. Dietary reference values of individual micronutrients and nutriomes for genome damage prevention: current status and a road map to the future. Am. J. Clin. Nutr. 2010, 91:1438S-1454S.
116. Dolle M.E., Giese H., van Steeg H., Vijg J. Mutation accumulation in vivo and the importance of genome stability in aging and cancer. Results Probl. Cell Differ. 2000, 29:165-180.
117. Milman N. Iron prophylaxis in pregnancy-general or individual and in which dose?. Ann. Hematol. 2006, 85:821-828.
118. Pena-Rosas J.P., Viteri F.E. Effects and safety of preventive oral iron or iron plus folic acid supplementation for women during pregnancy. Cochrane Database Syst. Rev. 2009, 4. CD004736.
119. Zhou S.J., Gibson R.A., Crowther C.A., Makrides M. Should we lower the dose of iron when treating anaemia in pregnancy? A randomized dose-response trial. Eur. J. Clin. Nutr. 2009, 63:183-190.
120. De Freitas J.M., Meneghini R. Iron and its sensitive balance in the cell. Mutat. Res. 2001, 475:153-159.
121. Ames B.N. A role for supplements in optimizing health: the metabolic tune-up. Arch. Biochem. Biophys. 2004, 423:227-234.
122. Fenech M. The Genome Health Clinic and Genome Health Nutrigenomics concepts: diagnosis and nutritional treatment of genome and epigenome damage on an individual basis. Mutagenesis 2005, 20:255-269.
123. Ames B.N. Micronutrients prevent cancer and delay aging. Toxicol. Lett. 1998, 102-103:5-18.
124. Fenech M., Crott J.W. Micronuclei, nucleoplasmic bridges and nuclear buds induced in folic acid deficient human lymphocytes-evidence for breakage-fusion-bridge cycles in the cytokinesis-block micronucleus assay. Mutat. Res. 2002, 504:131-136.